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INTRODUCTION
Ocular surface tumors encompass malignant, premalignant, and 
benign lesions arising from the conjunctiva, limbus, or cornea. These 
neoplasms may originate mainly from squamous epithelia, melano-
cytes, or lymphocyte cells(1). 
Clinical examination of the tumors based on slit-lamp biomi-
croscopy by a trained professional frequently yields a correct 
diagnosis, if the clinician is familiar with the clinical characteristics. 
However, in some instances, only a broad differential diagnosis 
is possible, and slit-lamp biomicroscopy cannot reliably exclude 
uncommon diag nosis such as amelanotic malignant melanoma, 
highlighting the importance of acquiring a clinical diagnosis before 
administering a treatment. The gold standard is obtaining a biopsy, 
either incisional or excisional, for histopathology. The main risk of 
clinical misdiagnosis of an excised benign lesion is exposing the pa-
tient to unnecessary surgery; to prevent this, adjunctive diagnostic 
tests can be performed(2). 
Diagnosis may be improved by cytological examination, 
high-resolution anterior segment ultrasound (UBM), in vivo confocal 
microscopy, and optical coherence tomography. Cytological sam-
pling is a relatively noninvasive method and is thereby preferable 
when treatment with nonsurgical techniques such as administration 
of a topical chemotherapeutic agent with an antineoplastic drug is 
considered(3). It may also assist in evaluating lesions in cases where 
surgery may not be appropriate, including patients not medically fit 
for surgical biopsy(4). In 1954, Larmande and Timsit were the first to 
use cytodiagnosis in ophthalmology to assist in the evaluation of 
tumors of the sclerocorneal limbus(5). 
Ocular surface cytology can be performed by several methods, 
including spatula scraping, brush cytology, and impression cytology 
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ABSTRACT
Impression cytology (IC) has been widely used as a method for evaluating the ocular 
surface and superficial cells layers in the diagnosis and follow-up after treatment 
of several ocular surface tumors of both epithelial and melanocytic origin. Infor-
mation regarding this can be found in the English-language literature since 1992. 
Using either cellulose acetate or Biopore membranes for specimen collection, a 
high correlation has been found between IC and tissue histology. Compared with 
exfoliative cytology with spatula, IC is less traumatic to the patient’s eye, provides a 
precise location of the area being studied, and allows accurate observation of the 
cells the way they exist in vivo. The additional advantage of IC is the preservation 
of limbal stem cells responsible for continuous corneal epithelium renewal; these 
can be affected after incisional or excisional biopsy at the corneoscleral limbus, 
which is the most frequent site of appearance of tumors in the stratified epithelium. 
Treatment for ocular surface squamous neoplasia has historically included surgery, 
but nonsurgical interventions have also been adopted. Hence, in certain cases, 
ophthalmologists may prefer interventions less invasive than surgical biopsy such 
as of impression cytology for both initial diagnosis and therapeutic monitoring of 
treatment for ocular surface lesions. Nevertheless, it should be considered that IC may 
be less helpful if the results conflict with the clinical picture or if the clinical diagnosis 
is uncertain and results are negative. In such cases, surgical biopsy is required for 
accurate diagnosis. The purpose of this review is to examine the published literature 
on the utilization of IC for the diagnosis and management of ocular surface tumors 
and to discuss the requirement for further investigation on the subject.
Keywords: Conjunctiva; Cornea; Limbus corneae; Conjunctival neoplasms/diag-
nosis; Eye neoplasms; Cytodiagnosis; Cytological techniques; Diagnostic techniques, 
oph thalmological; Review
RESUMO
A citologia de impressão (CI) tem sido amplamente utilizada como um método de 
avaliação da superfície ocular e das camadas de células superficiais no diagnóstico 
e no seguimento após tratamento de vários tumores da superfície ocular de origem 
epitelial ou melanocítica. As informações podem sem encontradas na literatura em 
língua inglesa desde 1992. Utilizando-se de membranas de acetato de celulose ou 
Biopore na coleta dos espécimes, uma alta correlação tem sido encontrada entre a 
CI e a histologia do tecido. Comparando-se com a citologia esfoliativa, a citologia 
de impressão é menos traumática para o olho do paciente, fornece uma localização 
precisa da área estudada e permite ver as células da forma como elas organizam-se 
in vivo. A vantagem adicional da citologia de impressão é a preservação das célu-
las-tronco germinativas responsáveis pela renovação contínua do epitélio da córnea. 
Elas podem ser afetadas após biópsia cirúrgica na região do limbo que é o sítio mais 
frequentemente acometido pelos tumores do epitélio estratificado. O tratamento 
para a neoplasia escamosa da superfície ocular tem sido historicamente a cirurgia, 
mas intervenções não cirúrgicas também foram adotadas. Por esta razão, em certos 
casos, oftalmologistas podem recorrer a formas menos invasivas que a biópsia cirúr-
gica (como a citologia de impressão) tanto para o diagnóstico inicial quanto para o 
monitoramento terapêutico das lesões da superfície ocular. No entanto, deve-se ter 
em mente que a citologia de impressão deixa de ser útil quando seu resultado não 
coincide com o quadro clínico ou quando o diagnóstico clínico é incerto e o resultado 
da citologia de impressão negativo. Nesses casos, a biópsia cirúrgica deve ser realizada 
para o diagnóstico. O objetivo desta revisão é examinar a literatura sobre a utilização 
da citologia de impressão no diagnóstico e tratamento dos tumores da superfície 
ocular bem como discutir a necessidade de uma investigação mais aprofundada 
sobre o assunto. 
Descritores: Túnica conjuntiva; Córnea; Limbo da córnea; Neoplasias da túnica con-
juntiva/diagnóstico; Neoplasias oculares; Citodiagnóstico; Técnicas citológicas; Técnicas 
de diagnóstico oftalmológico; Revisão
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(IC). IC is a well-established technique for collecting superficial epi-
thelial layers by applying collecting devices (either cellulose acetate 
filter papers or Biopore membrane device), so that cells adhere to 
their surface and are removed from the eye to be processed further 
for analysis by various appropriate methods. IC was first developed 
to diagnose dry-eye status, and it is now used to diagnose various 
ocular surface disorders, including neoplasia. It represents a non- or 
minimally invasive biopsy technique applicable to the conjunctiva, 
cornea, and limbal area for both diagnosis and follow-up after treat-
ment of tumors(6). Because repeated surgical biopsies of suspicious 
ocular surface lesions may cause complications such as scarring, lid 
deformity, limbal stem cell deficiency (LSCD), and great discomfort 
to the patient, IC can assist in the evaluation(4). 
The present review examines and updates the published literature 
on the utilization of IC for the diagnosis and management of ocular 
surface tumors and discusses the requirement for further investiga-
tion on the subject.
IC TeChNIqUe 
After a complete ophthalmological examination, including slit- 
lamp biomicroscopy, IC can be performed according to methods 
previously described(4). A drop of topical anesthesia is consistently 
used. Then, the collection of the superficial cell layers of the ocular 
surface is performed by forceps-assisted application of a membrane 
with submicroscopic pores, such as MF-Millipore, onto the patient’s 
lesion. Membranes are often precut in different shapes and sizes for 
orientation purposes during processing. Most authors agree to using 
membranes with pore sizes ranging 0.025-0.45 µm. It is essential 
to consider the pore size because it affects the consistency of cell 
collection (the larger the pore size, greater the cellularity) and the re -
solution of the details under the microscope (morphology was better 
preserved in the smaller pore size papers). The membrane is firmly 
pressed against the area to be sampled with the aid of a swab or a 
solid rod for some seconds and then peeled off using the forceps. 
Whenever needed, more samples can be collected. They are imme-
diately transferred to be fixed in a solution containing glacial acetic 
acid, 37% formaldehyde, and ethyl alcohol in a 1:1:20 volume ratio, 
taking care to completely immerse the membranes. After samples 
have been fixed, different staining techniques can be performed 
laboratory analysis. The most used stains include periodic acid-Schiff 
(PAS), hematoxylin-eosin, Gill’s hematoxylin, and Papanicolaou. The 
cells can be mounted on a slide after fixation and staining ready for 
interpretation. PAS is used to stain goblet cells and their secretions 
and hematoxylin as a counterstain to stain epithelial cells. Papani-
colaou helps to better interpret the epithelial changes of squamous 
metaplasia and the distinct nuclear patterns. These stains have also 
been used together. Although over the last decade several techni-
ques have used IC samples, light microscopy remains the most used 
method. To evaluate IC specimens by light microscopy, several featu-
res are universally evaluated: the morphology of the epithelial cells, 
the degree of squamous metaplasia, the nuclear to cytoplasmic (N/C) 
ratio; the density, shape, and PAS intensity of goblet cells present; 
and the presence of nonepithelial cells, including inflammatory cells, 
melanocytic cells, and microorganisms. Atypical cells are identified 
by the presence of nuclear enlargement, hyperchromasia, irregular 
nuclear outline, and coarse nuclear chromatin and eventually by the 
presence of prominent nucleoli, under magnifications of 100×, 200×, 
and 400×. If different types of atypical cells are observed in the same 
specimen, more severe stage is considered. 
ApplicAtion of ic in the evAluAtion of lesions of  
melAnocytic origin
Lesions of melanocytic origin are as common as epithelial tumors 
and include conjunctival racial melanosis, primary acquired mela-
nosis (PAM), secondary melanosis, nevus, and melanoma. Although 
majority of the melanocytic lesions are benign, some can be malig-
nant; therefore, distinguishing various conjunctival lesions is crucial(7). 
The first IC study of pigmented lesions from the conjunctiva 
was published in 1992(8). A 73% correlation between IC and histo-
pathology was observed in the diagnosis of 24 tumors, of which 
three were nevi, nine were melanomas, 10 were cases of PAM, and 
two were cases of secondary melanosis; examples are shown in fi-
gure 1. An increased nuclear-to-cytoplasmic (NC) ratio, an irregular 
nuclear chromatin pattern, the presence of large nucleoli, and the 
observation of mitosis and anisokaryosis were regarded as cytolo-
gical features of malignancy in cells containing melanin. When the 
relative proportion of atypical melanocytes was low, lesions were 
cytologically diagnosed as premalignant melanosis equivalent to 
the histological diagnosis PAM with atypia. If cancerous cells were 
abundant, the diagnosis was suggestive of melanoma. The authors 
reported that repeated examinations may increase the sensitivity of 
the cytological technique. Authors stated that although a diagnostic 
biopsy may remain necessary for determination of the origin and 
extent of those lesions, recurrent tumors or suspicious areas may be 
biopsied less frequently using IC, thus reducing the risk of side effects 
and patient discomfort(8). 
In 2007, a study revealed 68 melanocytic conjunctival lesions, 
of which 31 were nevi, nine were melanoma, and 28 were PAM. The 
authors compared the Biopore membrane IC (referred to as “Biopore”) 
with exfoliative cytology (EC) in these lesions. Twenty-three of the 26 
samples analyzed by Biopore and 20 of the 24 samples analyzed by EC 
correlated with the corresponding histology. Biopore accurately pre-
dicted the outcome in 88% and EC in 83% of the lesions. The authors 
concluded that Biopore could be used in cytology of melanocytic 
lesions and was easier and faster to interpret than EC. If difficult 
with Biopore, sampling of the fornix, caruncula, and ocular material 
in children could be performed by EC. Because some melanocytic 
lesions will be covered with one or more layers of normal epithelium, 
cytology could only provide a realistic picture of a lesion when it was 
able to sample deeper than the most superficial layer of epithelial 
cells. Biopore, however, may sample only the first layer of cells on 
the conjunctiva, unless it is repeated several times to acquire cells of 
deeper layers(9). Similarly, IC with cellulose acetate filters was able to 
sample deeper layers when performed repeatedly(10).
A case of a patient with an irregular pigmented lesion of the 
lower eyelid margin simulating malignant tumor, which was treated 
based on the results of IC and diagnosed with secondary melanosis 
by histology, was presented in 2009. The importance of IC was em-
phasized as an effective and safe method circumventing unnecessary 
and extensive procedures(11). 
A few melanocytic lesions, including four nevi and one melano-
ma, were examined in another study, and for such cases, results of 
both IC and histopathological features correlated(5). 
IC features of 35 conjunctival nevi from children and adults re-
ferred to as more noticeable were described in 2009. Approximately 
26% were amelanotic but could be identified as localized areas of 
hyperemia. Using criteria derived from histology, IC was reported for 
conjunctival nevi when nests or clusters of nevus cells were observed 
within the epithelium layer containing or not containing mucous- 
secreting goblet cells. Epithelial cell layers demonstrated normal mor-
phology, or, when the lesion was elevated, showed signs of squamous 
metaplasia (SM). IC confirmed the clinical diagnosis by demonstrating 
typical histopathological features of the superficial layers of conjunc-
tival nevi in 91.4% of the cases. For amelanotic nevi, IC also allows 
differential diagnosis from other non-pigmented lesions(12).
Recently, a case of an amelanotic corneally displaced malignant 
conjunctival melanoma was described. The authors showed that 
IC performed prior to the treatment provided the first clue for the 
diagnosis later confirmed by histopathology. IC samples revealed 
abundant clusters of pleomorphic atypical tumor-dissociated cells 
with different sizes and anisokaryosis characterized by large and irre-
gular nuclei with occasionally prominent nucleoli in a cytomorpho-
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logy not resembling epithelial cells. Some of the atypical cells were 
spindle-shaped. Melanin pigment was absent. A few nonneoplastic 
squamous epithelial cells were also observed. Clinical diagnosis of 
amelanotic melanoma is challenging, and IC can assist in supporting 
the initial diagnosis when interpreted by a trained cytologist or un-
der guidance of an ocular pathologist. For amelanotic melanoma, IC 
enables differential diagnosis from other nonpigmented lesions(13). In 
addition, incisional biopsy of melanoma should be avoided because 
of the risk of local tumor dissemination(14). 
ApplicAtion of ic in the evAluAtion of lesions of  
epitheliAl origin
Ocular surface squamous neoplasia (OSSN) is the most common 
tumor of the ocular surface. The spectrum of OSSN ranges from mild 
to severe dysplasia, through full-thickness epithelial involvement, 
to invasive squamous cell carcinoma (SCC). Although the clinical 
appearance of a lesion can be suggestive of OSSN, tissue biopsy is 
necessary to confirm the diagnosis because the different stages of 
OSSN are extremely difficult to distinguish by slit-lamp biomicrosco-
py, with an accuracy of clinical diagnosis by experienced clinicians of 
approximately 40%(3). 
It has been reported that IC immunostained with cytokeratin 
antibodies and HMB-45 was useful to differentiate a pigmented con-
junctival seborrheic keratosis masquerading as malignant melano-
ma. IC disclosed basaloid cells intermixing with squamoid cells, and 
these cells demonstrated positive immunoreactivity to cytokeratin 
and no reactivity to HMB-45 and therefore were proven to represent 
an epithelium-derived tumor despite of being pigmented. This re-
port illustrated that IC combined with immunocytochemical staining 
may be a valuable diagnostic aid in the differentiation of pigmented 
conjunctival tumors prior to treatment(15).
The published correlation rate with IC for predicting the subse-
quent histological findings ranged between 77% (55/71) and 80% 
(20/25), and both cellulose acetate(16) and Biopore membranes(17) 
have been successfully used. The difficulty in interpreting these IC 
specimens caused by the paucity of published criteria was overcome 
with the publication by Nolan et al., who described in detail the cyto-
morphology of OSSN based on a high number of cases. The following 
cytological criteria were used to diagnose intraepithelial OSSN: nuclear 
enlargement (more than two times the dimensions of the nucleus 
of normal conjunctival cells), presence of irregular nuclear contour, 
coarsely clumped chromatin, nuclear pleomorphism, binucleation 
or multinucleation, and evident nucleoli. When nuclear enlargement 
was less than twice the dimensions in normal conjunctival cells or 
when it was limited to only few squamous cells, the specimen was ca-
tegorized as having atypical squamous cells indefinite for dysplasia. If 
none of the abovementioned characteristics was observed, the spe-
cimen was regarded negative. The finding of syncytia-like groupings, 
intraepithelial infiltration of inflammatory cells, and macronucleoli 
may be suggestive of SCC in some samples(18). Nevertheless, at pre-
sent, no unique specific cytological feature to differentiate SCC from 
intraepithelial lesions in IC specimens has been identified. According 
Figure 1. Examples of IC in the evaluation of lesions of melanocytic origin: A) Anterior segment slit-lamp photograph demonstrating a conjuncti-
val nevus. B) IC obtained from the same lesion demonstrating a cluster of nevus cells (arrow) among epithelial cells (Hematoxylin-Eosin staining; 
original magnification, 400×). C) Anterior segment slit-lamp photograph of malignant melanoma. D) IC obtained from the sample depicted in (C) 
demonstrated clusters of pleomorphic atypical tumor-dissociated cells with different sizes and anisokaryosis characterized by large and irregular 
nuclei in a cytomorphology not resembling epithelial cells. Brown melanin granules can be seen inside the cytoplasm of the malignant melanocytes 
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to these reports, there were no false-positives identified by IC(16-19). 
Examples are shown in figure 2. 
Notably, the cytology of subclinical intraepithelial OSSN has 
al ready been described. The cytological pattern for OSSN with no 
clinically visible abnormality differed from that observed in the eyes 
with clinically detectable disease; there were often a few dysplastic 
cells lying within sheets of normal epithelium(18). 
In 2002, Chan et al. showed that IC obtained from surface cells 
overlying a pterygium was abnormal, typically exhibiting SM with 
increased goblet cell density. Altered cytology could also be de-
monstrated in the inferior bulbar conjunctiva and interpalpebral 
conjunctiva, without clinical evidence of pterygium. This suggested 
a graded series of changes occurring throughout the bulbar conjunc-
tiva, with the most advanced occurring directly over the pterygium, 
confirming that it was indeed an ocular surface disorder(20).
A case of conjunctiva-cornea intraepithelial neoplasia (CCIN) 
treated with topical mitomycin-C (MMC) and interferon alfa-2b in 
cycles was described in 2003. The patient was referred for LCSD and 
epithelial defect but IC specimens were suggestive of CCIN. After 
differentiation from LCSD by dye staining and IC, the patient was 
successfully treated(21).
Another study found that IC had a positive and negative predic-
tive value of 97.4% and 53.9%, respectively, when compared with 
histology(5). 
In 2009, Barros et al. described an index score modified from the 
Bethesda system for reporting cervical cytologic diagnoses to diffe-
rentiate SCC from pre-invasive ocular surface lesions by IC (n=39). 
They revealed a predictive index score of ≥4.25 representing the 
best cut-off point for SCC with a sensitivity of 95%, specificity of 93%, 
positive predictive value of 95%, and negative predictive value of 
93%(4). Four of seven parameters included in their regression model 
(nuclear enlargement >three-fold, syncytial-like groupings, increased 
NC ratio, and indistinct cytoplasm border) were visible using clinical 
confocal microscopy (CCM). One parameter (prominent nucleoli) is 
currently undetectable by CCM. The last two parameters (cellular 
hyperchromasia and eosinophilic cytoplasm) would require specific 
stains unavailable in vivo. The introduction of in vivo stains or bio-
markers to better visualize these cellular details would be useful to 
improve image quality and to obtain more detailed information. A 
novel CCM specific index score to differentiate SCC from preinvasive 
ocular surface lesions is still necessary(22). 
IC may be less sensitive for cases with keratotic lesions because 
an abundance of surface keratin can make sampling inaccurate(5). To 
minimize this problem, authors have recommended collecting at 
least two samples over the same area from a suspicious lesion(4,23). 
For diagnosing OSSN, adding a second and a third evaluation of IC 
provided significantly more sensitivity than including only one(23). 
Nevertheless, it should considered that IC is very helpful, unless the 
result conflicts with the clinical scenario or when the actual clinical 





Figure 2. Example of IC in the evaluation of lesions of epithelial origin (ocular surface squamous neoplasia): A) Anterior segment slit-lamp photograph 
demonstrating conjunctival intraepithelial neoplasia. B) IC obtained from this lesion demonstrating atypical epithelial cells with mild nuclear enlar-
gement, anisokaryosis, and remarkable hyperchromasia (Hematoxylin-Eosin staining; original magnification, 400×). C) Anterior segment slit-lamp 
photograph of invasive squamous cell carcinoma of the conjunctiva. D) IC demonstrating atypical epithelial cells showing nuclear enlargement, 
marked increase in the nuclear-to-cytoplasmic ratio, anisokaryosis, hyperchromasia, and a syncytial-like arrangement with absence of well-defined 
cytoplasmic borders (Hematoxylin-Eosin staining; original magnification, 400×).
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cal biopsy needs to be performed for accurate diagnosis(5,23).
In the study by Ballalai et al., 0.02% topical MMC was used to 
treat patients with OSSN. Before the treatment, cytology showed the 
presence of neoplastic cells in patients with primary tumors, avoiding 
surgical biopsy and treatment delay(24). 
A great advantage of using IC is the preservation of limbal stem cells, 
responsible for renewal of corneal epithelium throughout life. In most 
OSSN cases, the lesions affect predominantly the limbus and have a ten-
dency to recur. IC offers a safer tool for diagnosis than repeated biopsy(4). 
Moreover, IC can be used during post-surgery fol low-up to identify any 
recurrence of the disease as well as the effects of topical treatment such 
as chemotherapy with antineoplastic drugs like MMC(25). 
ApplicAtion of ic following tumor treAtment 
Treatment for OSSN has historically been surgery but nonsurgical 
interventions have also been adopted. Adjunctive therapies allowed 
the treatment of subclinical disease at a site different from that of the 
clinically evident tumor. Nevertheless, topical chemotherapeutic drugs 
can be potentially toxic to the ocular surface(26). In 2001, IC was used 
to study the effects of topical MMC in the treatment of OSSN; 0.04% 
MMC induced cell death mainly by apoptosis or rarely by necrosis and 
changes induced in the ocular surface persisted for at least 8 months. 
MMC induced cytomegaly, cytoplasmic vacuolation, nucleomegaly 
with nuclear wrinkling, and binucleation or multinucleation. The N/C 
ratio in these enlarged cells was normal. These changes mimicked 
those observed following radiation therapy in uterine cervical cancer. 
Nuclear and cell size increased along with increasing N/C ratio in 
some dysplastic cells(25). Yamamoto et al. used IC during diagnosis and 
follow-up, resulting in successful treatment with 5-fluorouracil of an 
intraepithelial OSSN with LSCD that was refractive to topical MMC(27). 
Dogru et al. evaluated the tear function and ocular surface alte-
rations in patients with primary intraepithelial OSSN before and after 
treatment with 0.04% topical MMC. Initial IC specimens showed loss of 
goblet cells, higher grades of SM, and areas of isolated keratinized, bi-
nucleated, and actively mitotic disfigured epithelial cells in all patients. 
The mean goblet cell density and SM grade were observed to having 
significantly improved at the last visit of the patients. IC proved useful 
in attaining the diagnosis of OSSN, evaluating the effect of treatment 
and showing MMC-related long-term changes on the ocular surface(28). 
In 2005, Prabhasawat et al. reported complete tumor regression 
observed clinically and by IC, demonstrating the efficacy of 0.002% 
topical MMC as an adjunctive and alternative treatment in primary 
and recurrent OSSN; IC exhibited tumor-free specimens with cellular 
elongation as a result of chemotherapy(29). 
Notably, cytological changes mimicking malignancy have been 
reported in conjunctiva up to 6 weeks following topical MMC thera-
py. Nevertheless, there are features which help to differentiate these 
changes: epithelial cells affected by the drug show a proportionate 
increase in both cytoplasm and nucleus, preserving a normal NC ratio 
(cytomegaly), unlike the case of increased NC ratio (cariomegaly) in 
OSSN. The distinction of MMC-related changes from OSSN cells in IC 
specimens can be performed when the cell border is clearly visible 
and the N/C ratio can be estimated. Differentiation becomes difficult 
in cells with large hyperchromatic nuclei where the cell outline is not 
clearly defined because of overlapping cells or attenuation of the 
vacuolated cytoplasm. Therefore, studying such cells for which cell 
size can be clearly assessed is crucial(25).
Westekemper et al. examined ocular surface integrity of ten pa-
tients with large and diffuse conjunctival melanoma who underwent 
proton beam radiation. The IC revealed conjunctival SM in nine cases, 
indicating a radiogenic, persisting disturbance in the differentiation 
of the conjunctival epithelial cells. The tear film instability correlated 
with goblet cell loss and meibomian gland dysfunction(30).
The use of topical MMC has been described by some authors not 
only for OSSN but also for melanocytic lesions such as PAM with aty-
pia. However, its prolonged use may be associated with a high inci-
dence of complications like LSCD. IC diagnoses ocular surface lesions 
and also evaluates possible local side effects following treatment. 
Five cases of proven LSCD by IC resulting as a complication of topical 
treatment with MMC for PAM with atypia have been reported(31).
Rodríguez Feijoo et al. reported that making an accurate diffe-
rential diagnosis between keratoacanthoma and SCC by histology 
as well as carrying out close monitoring after surgery due to the 
possibility of relapse and conversion to SCC is important. Therefore, 
they proposed the use of IC as a method for monitoring such pa-
tients. After the treatment, IC exhibited large altered epithelial cells 
with intracellular union changes and an NC ratio of 1:20. A second 
series of IC tests performed 3 months after the first series showed 
the same results(32). 
Recently, Faramarzi and Feizi evaluated the efficacy of perilesio-
nal/subconjunctival injections of an antivascular endothelial growth 
factor, bevacizumab, for treatment of a group of 10 eyes with primary 
OSSN. Based on clinical presentation and IC results, they showed that 
the treatment was effective in terms of decreasing the size of con-
junctival OSSN when the lesion was limited to the conjunctiva. Howe-
ver, this therapy had no effect on corneal extensions of the OSSN(33).
ApplicAtion of ic in the evAluAtion of tumors of  
sebAceous origin
In 2003, Sawada et al. demonstrated that IC detected conjunc-
tival intraepithelial invasion from sebaceous cell carcinoma of the 
eyelid in four patients with severe unilateral blepharoconjunctivitis. 
IC showed numerous inflammatory cells and abnormal tumor cells 
with atypia and characteristic cytoplasmic vacuoles, consistent with 
dissolved sebaceous contents(34-35). They represented areas where 
lipid was contained before it was dissolved by alcohol; an example 
is shown in figure 3. The diagnosis was confirmed by histology from 
full-thickness wedge resection of the eyelids. When pagetoid spread 
in advanced cases of sebaceous cell carcinoma results in a superficial 
or full-thickness replacement of the normal conjunctival epithelium 
with tumor cells, the superficial abnormal cells can be detected by 
IC. However, areas on the conjunctiva with pagetoid spread may exist 
without full-thickness epithelial disease. In such cases, IC may sam-
ple only the superficial normal epithelial cells and may fail to detect 
the tumor cells concealed in the deeper layers. Because sebaceous 
carcinoma can masquerade as several benign conditions such as 
blepharitis, the investigations should include IC and biopsy in cases 
that are not responsive to medication. If cellular atypia is present, a 
full-thickness lid biopsy should be performed(34). 
ApplicAtion of ic in the evAluAtion of ulcerAtive eyelid mAlignAncy
Thirty-two histopathologically proven malignant eyelid lesions 
diagnosed over a 2-year period, including 13 basal cell carcinomas, 11 
sebaceous carcinomas, four SCC, two malignant melanomas, and two 
poorly differentiated carcinomas, formed the study group described 
very recently. The results of IC were compared with those of obtained 
by histopathological analysis in the study group and with an age- and 
sex-matched group of benign cases as controls. The sensitivity of IC 
was 84% (27/32) for the diagnosis of malignancy and 28% (9/32) for 
categorization of the type of malignancy. Because of its low sensiti-
vity in terms of cytological categorization of the type of malignancy, 
IC cannot be recommended in the primary diagnosis of eyelid ma-
lignancies. Nevertheless, with experience and improvement in the 
technique, it may prove to be a useful tool in deciding future mana-
gement, particularly in recurrences of histopathologically confirmed 
eyelid malignancies, where biopsies may be avoided(36). 
ic, imAging, And histopAthology 
Clinical examination is subjective, is unable to assess cellular 
morphology, and may not detect subclinical microscopic diseases. A 
surgical biopsy to confirm the resolution of an OSSN could miss small 
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residual lesions. Thus, an incisional biopsy may miss lesions that were 
not included in the excised tissue. The biopsy is based on clinically vi-
sible disease and may produce false-negative results. The false clinical 
impression of tumor resolution can result in premature termination of 
topical treatment and an increased risk of recurrence. These lesions 
can spread along the basal conjunctival layers far beyond the clinical 
lesion, and thus may be missed clinically. Excisional biopsy, despite 
being the most traditional and accurate means, may induce conjunc-
tival scarring, LSCD, and visually disturbing corneal scarring. Due to 
the multifocal nature of OSSN, surgical excision results in extensive 
collateral damage to adjacent areas of normal epithelium(37).
In addition to IC, newer diagnostic techniques including CCM(22), 
toluidine blue(38), and ultra-high resolution anterior segment optical 
coherence tomography (UHR-OCT)(39) have been reported to aid in 
the diagnosis of OSSN. All these techniques have limitations and 
require skilled professionals to perform the tests and interpret the 
results. IC assesses only superficial layers of cells, which are not always 
representative of deeper layers, whereas CCM does not provide cross- 
sectional views hence not being useful for determining the vertical 
and horizontal extent of the lesion. Therefore, ensuring that the exact 
same area of the ocular surface is analyzed by CMM at follow-up exa-
minations can be challenging. Regarding UHR-OCT, lesions, which 
are thickly pigmented lesions or show leukoplakia, tend to impede 
the penetration of light to deeper tissues, impairing the determina-
tion of the posterior limit of the lesion. Optical information at the time 
of the study was not sufficient to study signs of cellular atypia and 
was not able to rule out microinvasion(37). Similar to UHR-OCT, IC may 
not distinguish in situ from minimally invasive disease(6).
Each imaging modality has the advantage of being noninvasive, 
and each has been is useful in the detection of OSSN. However, both 
UBM and some confocal microscopy devices require contact with 
the ocular surface, increasing both the length of time and technical 
expertise required for their performance. Furthermore, although 
confocal microscopy has the advantage of detailing individual cell 
morphology, which is currently outside of the capability of UHR-OCT, 
it targets a very limited area. OCT has the advantage of higher-reso-
lution images, but shadowing may occur in thick lesions or those 
with leukoplakia. UBM has greater depth of penetration but lower 
resolution and cannot evaluate the epithelial versus subepithelial 
nature of a lesion. No data are available regarding inter- and intra-
observer variability for the assessment of ocular surface pathology 
using the UHR-OCT(40). Despite UHR-OCT having the advantage over 
IC of providing relatively deeper scans of the entire epithelium and 
the underlying tissue, it cannot reliably detect invasion(37). In addition, 
UHR-OCT machines are largely limited to academic institutions(39).
IC may be an inexpensive tool that can be used in the outpatient 
clinic setting to help provide an objective evaluation of suspicious 
lesions that enables patients to make better informed decisions 
regarding the treatment requirements. Results of IC may also help 
the ophthalmologist decide whether incisional or excisional biopsy 
should be performed and whether any other associated procedures, 
such as freeze-thaw cryotherapy of the sclera/limbus and/or ethanol 
application to the cornea, are required. IC provides a flat mount of an 
area as large as the size of the applied filter paper with well-preserved 
morphology. In comparison, conjunctival smears destroy much of the 
morphological information and conjunctival biopsies provide infor-
mation from a relatively small sample of the surface epithelium, both 
because of the difficulty of preparing flat mounts and because of their 
small sizes. Therefore, IC is ideal for sampling the corneal epithelium(40). 
FINAL COMMeNTS
OSSN masquerades as scar tissue or pannus; in addition, it can 
appear in association with pterygia(3). Thus, the question of using IC 
for the detection of OSSN in the setting of concomitant ocular surface 
disease requires further studies. Recently, Barros et al. reported that IC 
demonstrated high agreement with the results of the histopatholo-
gical analysis for detecting atypical epithelial cells from unsuspected 
OSSN in cases of pterygia from Brazil, showing unsuspected and 
associated OSSN cells in 13 specimens (40%)(41).
IC presents great advantages: (1) it provides a source of intact 
and well-preserved epithelial cells from the ocular surface in any type 
of ocular surface pathology; (2) it is a nonsurgical, easy-to-perform, 
quick, and inexpensive technique that can always be performed on 
an outpatient basis; (3) only topical anesthesia is required, and no side 
effects or contraindications have ever been noted and thus it can be 
applied to children; (4) repeated IC sampling in the same patient over 
time is an excellent way to demonstrate changes due to a certain 
event, to monitor the progress of a disease, or to follow the effect 
of a therapeutic intervention; (5) IC maintains cell-to-cell contacts, 
preventing the problems of EC or brush cytology, which may destroy 
much of the cell morphology, cause overlapping of cells, and ham-
per clear visualization of the in vivo arrangement of the cells; (6) IC 
samples can be processed using any type of microscopy in addition 
to polymerase chain reaction (PCR), immunoblotting analyses, and/or 
flow cytometry. Based on all these advantages, IC has become the 
technique of choice for sampling ocular surface epithelium for being 
a very useful research tool in both basic and clinical aspects(41-42). 
A B
Figure 3. A) Anterior segment slit-lamp photograph demonstrating conjunctival intraepithelial invasion from a sebaceous cell carcinoma of the 
eyelid. B) IC showing inflammatory cells and a tumor cell with atypia, abnormal prominent nucleoli, and characteristic cytoplasmic vacuoles (arrow) 
consistent with intracellular dissolved sebaceous contents. These cells were PAS-negative, suggestive of non-goblet cell origin. No evident goblet 
cells were observed in the epithelium (PAS and Hematoxylin-Eosin staining; original magnification, 400×). 
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Although IC cannot replace histology, it has an important role in 
the diagnosis and management of patients with OSSN in a less in-
vasive manner. A tool such as IC that aids the diagnosis of OSSN is of 
particular relevance to Brazilian patients, who live in a country closer 
to the equator line, with a climate and an ultraviolet-B light index 
that may contribute to the appearance and development of such 
tumors in its population. The correlation between sun exposure and 
OSSN has been well established(43). The importance of IC lies in its 
capacity to detect both the presence and extent of OSSN when the 
clinical diagnosis is difficult, to detect subclinical disease and follow 
up on previously diagnosed disease(4,18). Expertise in IC is acquired by 
continuing experience including close reviews, correlation with all 
possible subsequent histology specimens, and clinicopathological 
correlation. This enables the cytologist to gain familiarity and become 
aware of the eventual difficult areas such as keratinizing lesions(17). 
Because IC has not presented sensitivity and specificity of 100%, 
the prospective use of the Barros score for predicting SCC needs to 
be further evaluated using a large number of patients(4). The develop-
ment of a novel immunohistochemical analysis with a proliferative 
index such as that for Ki-67 could aid in IC specimens becoming a 
diagnostic marker for OSSN and in obtaining prognostic information 
regarding the risk of recurrence in a manner similar to the current 
use of histology(44). This combination of IC and immunocytochemistry 
was first described by Krenzer and Freddo in normal human conjunc-
tiva in 1997, enabling the simultaneous evaluation of IC specimens 
for immunoreactivity to cytokeratin and morphological details(45). 
Nevertheless, as indicated in this review, there was only a single 
case(15) using this combined technique in the evaluation of an ocular 
surface tumor. Thus, the sensitivity and reliability of IC combined with 
immunocytochemical staining in the differentiation of ocular surface 
tumors need further evaluation in large-scale studies. 
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